sellModerate
Douglas Murphy-Chutorian sold $308k of SMLR
CEO at Semler Scientific, Inc.. 10,881 shares at an average of $28.34, traded Aug 28, 2024, filed Sep 6, 2024.
Warning score
49Value
$308k
10,881 shares
Holdings after
26,742
-29% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- +14Trade size$308k at market
- +10Share of holdings soldSold 29% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001104659-24-097762, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 28, 2024 | SOpen-market sale Common Stock | -780 | $28.32 | $22k | 36,843 | Sep 6, 2024 |
| Aug 29, 2024 | SOpen-market sale Common Stock | -10,101 | $28.34 | $286k | 26,742 | Sep 6, 2024 |
Related signals
Other insiders at Semler Scientific, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 55Moderate | SMLRsell Semler Scientific, Inc. | Douglas Murphy-Chutorian CEO, interim CFO and Director | $1.4M 70,406 shares | -56% | |
| 43Moderate | SMLRsell Semler Scientific, Inc. | Douglas Murphy-Chutorian Chief Executive Officer | $874k 28,604 shares | -48% | |
| 55Moderate | SMLRsell Semler Scientific, Inc. | Douglas Murphy-Chutorian CEO | $6.1M 100,000 shares | -71% | |
| 55Moderate | SMLRsell Semler Scientific, Inc. | Douglas Murphy-Chutorian CEO | $1.9M 50,000 shares | -50% | |
| 43Moderate | SMLRbuy Semler Scientific, Inc. | Eric Semler director | $1.9M 50,000 shares | +9% | |
| 44Moderate | SMLRsell Semler Scientific, Inc. | Douglas Murphy-Chutorian CEO | $306k 10,780 shares | -15% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.